Skip to main content
SGRY
NASDAQ Life Sciences

Surgery Partners Posts 3-Cent Adjusted Loss Per Share for First Quarter

Reported by Dow Jones Newswires
Sentiment info
Negative
Importance info
8
Price
$14.45
Mkt Cap
$1.838B
52W Low
$11.41
52W High
$24.18
Market data snapshot near publication time

Summary

Surgery Partners, Inc. has reported an adjusted loss of 3 cents per share for its first quarter. This announcement provides the first look at the company's quarterly performance following its full-year 2025 results detailed in the 10-K filed on March 3, 2026. Quarterly earnings reports are a critical catalyst for stock movement, and an adjusted loss, even if modest, indicates a lack of profitability on an adjusted basis for the period. Traders will be closely watching for the full earnings release and management's commentary on revenue, operational performance, and future guidance to assess the company's trajectory.

At the time of this announcement, SGRY was trading at $14.45 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.8B. The 52-week trading range was $11.41 to $24.18. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

SGRY - Latest Insights

SGRY
May 05, 2026, 7:31 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $14.45
Real-time Price: $14.53 info
Change: +$0.080 (+0.55%) info
Market Cap: $1.9B info
SGRY
May 05, 2026, 7:30 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $14.45
Real-time Price: $14.53 info
Change: +$0.080 (+0.55%) info
Market Cap: $1.9B info
SGRY
Mar 02, 2026, 5:15 PM EST
Source: Wiseek News
Importance Score:
8
Price at Filing: $12.20
Real-time Price: $14.53 info
Change: +$2.33 (+19%) info
Market Cap: $1.9B info
SGRY
Mar 02, 2026, 5:11 PM EST
Filing Type: 10-K
Importance Score:
9
Price at Filing: $12.29
Real-time Price: $14.53 info
Change: +$2.24 (+18%) info
Market Cap: $1.9B info